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a heterologous sarcomatous component: case
report and review of the literature
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Adult testicular granulosa cell tumors are rare sex cord- stromal tumors of which only 45 have been previously
reported. As compared with their ovarian counterparts, these tumors may follow a more aggressive course because
the proportion of malignant cases is higher. We report here a unique case of a 78-year Caucasian with a left sided
adult type granulosa cell tumor with a heterologous sarcomatous tumor component. A heterologous sarcomatous
component has occasionally been observed in ovarian tumors but never in testicular granulosa cell tumors. The
sarcomatous component showed a higher number of mitotic figures (1/Hpf) and a marked proliferation rate (up to
50% Ki 67 positive cells) compared with the granulosa type tumor component. CD 99 and the progesterone
receptor were positive in both tumor components, inhibin and calretinin only in the granulosa cells, and pancytokeratin
only in the sarcomatouse one. Key words: testis - ovary - granulosa cells - sarcoma - inhibin Runing title: testicular
sarcomatous granulosa tumor.
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6959043481207016Background
Tumors of sex cord/gonadal stroma are exceedingly rare
tumors that, in large series, account for 1.6–6% of adult
testicular tumors and occur somewhat more frequently
in children [1]. Teilum [2] used the term gonadal stroma
tumor as a histogenetic and morphologic designation for
tumors of both genders which derive from an undiffer-
entiated gonadal mesenchyme. They arise in the testis as
well as in the ovary. However, the incidence of the single
histological types differs widely between genders. Leydig
cell tumor is the most common stromal tumor of the
testis, followed by Sertoli cell tumors. Whereas granu-
losa cell tumors are typical for the ovaries.
The adult type of granulosa cell tumor is extremely rare
in the testis – 46 cases have been described to date (Table 1)
[3-31]. However, in most of the reports these tumors are
only the object of immunohistochemical or cytogenetical
investigations; thus, the clinical data are utterly or partially
missing [12,15,17,31]. In contrast to the adult type, the* Correspondence: Gregor.Mikuz@i-med.ac.at
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testicular tumor in boys younger than six months.
We observed an adult type granulosa cell tumor with a
heterologous sarcomatous tumor component, a morpho-
logical feature rarely observed in ovarian granulosa cell tu-
mors [32-34], and only in one testicular Leydig-Sertoli cell
tumor to date [35].Case report
A 78-year old Caucasian male was admitted to hospital
due to acute neurological symptoms. Upon exploration,
he reported a history of hypertension and arrhythmia.
Upon physical examination, an enlarged left testicle was
noted and an inguinal herniotomy scar on the left side.
According to statements by the patient, the testicle had
started to enlarge a year earlier. After neurological symp-
toms had remitted, the patient was transferred to the uro-
logical unit for further diagnostic procedures. A painless
and solid scrotal mass could be palpated on the left side.
The left epididymis was not discernible at palpation. The
right testicle and epididymis were unremarkable. Upon
ultrasonography, the mass had a diameter of 13 cm andal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 A synopsis of the morphological and clinical data of the up to now reported cases of the adult type granulosa
cell tumor originated in the testis
Case Age Testis Signs duration Endocrine symptoms Size cm Follow up Source
1 35 R 15 y gynecomastia 9 8.5 y NED Laskowski [3]
2 21 L incidental gynecomastia microscopic autopsy finding Cohen and Diamond [4]
3 53 R 1 y gynecomastia >10 NS Massachusetts General Hospital [5]
4 52 R 5 y none 13 NS Melicow [6]
5 41 L 8 y gynecomastia 10,1 5 mo DOD Mostofi et al. [7]
6 53 R 2 y gynecomastia 10 17 y NED Marshall et al. [8]
7 44 R few months none 3,5 3 y NED Talermann, 1985
8 41 R NS none 1.8 NS Gaylis et al. [11]
9 83 L NS none NS DOC Düe et al. [12]
10 61 R 2 mo none 5 2 y NED Nistal et al. [13]
11 26 L 7 mo gynecomastia 10 14 y NED Matoska et al. [14]
12 NS NS NS NS NS NS Sasano et al. [15]
13 42 L NS none NS AWD at surgery Monobe, Manabe [16]
14 57 R 10 y none 2,5 3 y DOC Jimenez-Quintero et al. [17]
15 55 L not known none 1,3 NS Jimenez-Quintero et al. [17]
16 60 L many years none 7 11 y 2 mo DOD Jimenez-Quintero et al. [17]
17 39 L 2 y none 4 3 y NED Jimenez-Quintero et al. [17]
18 16 L incidental none 1,8 4 mo NED Jimenez-Quintero et al. 1993
19 29 R incidental none 7,5 14 mo AWD Jimenez-Quintero et al. [17]
20 76 L incidental none 0,7 1 mo NED Jimenez-Quintero et al. [17]
21 NS NS NS NS NS NS Renshaw et al. [18]
22 NS NS NS NS NS NS Renshaw et al. [18]
23 NS NS NS NS NS NS Renshaw et al. [18]
24 NS NS NS NS NS NS Renshaw et al. [18]
25 NS NS NS NS NS NS Renshaw et al. [18]
26 NS NS NS NS NS NS Renshaw et al. [18]
27 51 L 2 mo incidental 7 13 mo NED Morgan,Brame [19]
28 48 R 3 y none 5 7 mo NED Al-Bozom et al. [20]
29 54 L incidental none NS NS Wang et al. [21]
30 33 NS incidental none 1 NS Guzzo et al. [22]
31 51 L incidental none NS 6 y AWD Suppiah et al. [23]
32 59 L 2 y none 15 4 y NED Hisano et al. [24]
33 32 L incidental none 1,98 NS Arzola et al. [25]
34 77 L incidental none 4 NS Lopez, [26]
35 45 R months none 6,5 2 y NED Ditonno et al. [27]
36 12 L 5 y none 10 NS Gupta et al. [28]
37 55 NS lung metastases none Hammerich et al. [29]
38 28 L incidental none 2,6 NS Song et al. [30]
39 21 L incidental none 1 2 y NED Hanson, Ambaye [31]
40 77 R NS NS 2,5 NS Lima et al. [36]
41 22 L NS NS 1 NS Lima et al. [36]
42 40 L NS NS 2,1 NS Lima et al. [36]
43 78 L incidental none 13 23 mo NOD recent case
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Figure 2 Tumor forms nest and cord composed of small cells
with scant cytoplasm and typical grooved, coffee bean-like
nuclei, resembling its ovarian counterpart. (H&E, orig.magni.x40).
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http://www.diagnosticpathology.org/content/9/1/107contained cystic spaces surrounded by solid tumor struc-
tures (Figure 1). There were no enlarged inguinal or ab-
dominal lymph nodes. Upon computed tomography of the
chest and abdomen, a cyst measuring 2.5 cm was found in
the right kidney, but masses raising suspicion of metasta-
ses were not detected. As a consequence of the clinical
findings, inguinal semicastration of the left testis was per-
formed. Twenty three months following surgery, the pa-
tient is alive and without signs of progressive disease.
Macroscopically the tumor was composed of solid white
or brownish firm masses with multiple cystic spaces.
Microscopically the tumor consisted of rather mono-
morphous typical granulosa cells with scanty cytoplasm
and angulated, coffee-bean like, grooved nuclei (Figure 2).
The cells grew mainly in solid patterns with some tra-
becular and gyriform areas and a few cysts lined by
tumor cells containing an eosinophilic fluid (Figure 3).
Some not well-differentiated microfollicular structures
resembling Call-Exner bodies could be found inter-
spersed (Figure 4). Mitotic figures were extremely rare.
The tumor showed central necrotic areas. The main
part of the tumor was surrounded by fibrotic tissue in
which small nests of undifferentiated, spindled cells or-
dered in sheets were located. These cells did not exhibit
any polymorphism and mitotic figures were lacking. AtFigure 1 Ultrasound view of a partly cystic tumor.the border of a hyalinized area a proliferation of large,
polygonal and spindled cells with many tumor giant
cells were present (Figures 5 and 6). The cells had a
clear or slightly eosinophylic cytoplasm and markedly
polymorphic nuclei with large nucleoli. Almost all mi-
totic figures (1/hpf) were atypical. Accordingly, the prolif-
eration rate of these sarcomatous cells, assessed by MIB-1
antibodies, was consistently higher (focally > 50%) than
that of the typical granulosa cells (<1%). Very large, spin-
dled sarcomatous cells were also found scattered among
fibrous collagen rich tissue. The sarcomatous area was in-
filtrated by a startling number of eosinophilic leucocytes.
Immunohistochemically, single typical granulosa cells
showed a week reactivity for inhibin and a strong but
patchy distributed reactivity for calretinin. Vimentin
and CD 99 (Figure 7) as well as progesterone receptor
(PR) were strongly expressed in the typical granulosaFigure 3 Granulosa cell tumor with cysts resembling the
ovarian follicle cysts (H&E, orig.magni.x4).
Figure 4 Higher magnification of the tumor shows cords and
follicular nesting of cells similar to those observed in granulosa
cell tumor of the ovary. The tumor cells are inhibin positive
(Inhibin immunohistochemistry, orig.magni.x20).
Figure 6 Sarcomatous area with bizarre multinucleated giant
cells embedded in a collagenous stroma and a marked
infiltration with eosinophils (H&E, orig.magni.x40).
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androgen- (AR) and estrogen-(ER) receptor antibodies did
not show any reactivity. Interestingly, the sarcomatous
tumor cells reacted strongly with pancytokeratin anti-
bodies (AE1:AE3) (Figure 5); by way of contrast, the typ-
ical granulosa cells were completely unreactive.
Since the FOXL2 402C→G (C134W) mutation is also
present in adult-type granulosa cell tumors occurring in
men, although in a smaller proportion when compared
with the rates reported in women [36], we also performed
this mutation analysis. To this end, DNA of the tumor
cells was extracted from serial sections (FFPE tissue) after
manual microdissection using the Maxwell 16 System
(Promega GmbH, Mannheim, Germany) in accordance
with manufacturer’s instructions.Figure 5 Sarcomatous area with spindled and stellate cells with
atypical mitoses. The insert shows pancytokeratin (AE1/AE3)
positive spindle cells of the sarcomatous area. (H&E and
immunohistochemistry,orig.magni.x40.Mutation hotspot region containing codon 134 was
amplified by PCR (primer sense: 5′- CAACTACTGGACG
CTGGACC-3′; primer antisense: 5′-GTTGCCCTTCTC
GAACATGTCT-3′). Sequencing analysis was performed
using the PyroMark Q24 system (Qiagen, Hilden,
Germany) in accordance with manufacturer’s instructions
(sequencing primer: 5′- CGCTGGACCCGGCCT-3′). De-
tailed information about PCR and sequencing conditions
is available on request. A FOXL2p.C134W mutation was
nonetheless not detectable.
Discussion
Adult type testicular granulosa cell tumors (GCT) are
rare sex cord–stromal tumors. However, subsequent to
a thorough study of the literature we were able to findFigure 7 A follicular structure with surrounding granulosa cells
strongly positive for CD 99. (CD 99 immunohistochemistry,
orig.magni.x20) orig.magni.x20).
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the recent literature reviews (28 cases) [31]. Fifteen out of
the 45 (33%) reported cases were published after the year
2000, which does not imply that incidence actually in-
creased, but rather, that the tumor is more frequently being
recognized.
Morphological diagnosis is based primarily on the typ-
ical morphology of the granulosa cells with their coffee-
bean like, angulated and grooved nuclei. Macrofollicles
ought to be present, the presence of the Call Exner bod-
ies makes correct diagnosis easier; however, they are not
always found and thus, are not indispensable to diagno-
sis [12]. Young and Scully [37] require that “all or almost
all” of the tumor should be composed of granulosa cells. In
fact, undifferentiated Sertoli cell tumors can have a very
similar cytomorphological features but form predominantly
ill-defined tubular structures resembling primitive testicular
tubules and do not have follicular structures. If the mor-
phological features are ambiguous, the term “incompletely
differentiated” (WHO) is preferable. The very rare fibrothe-
coma of the testis can be also mistaken for undifferentiated
sex cord tumor since it manifests the same immunoreactiv-
ity as all other stromal tumors. This tumor, however, is
composed of highly monotone spindle cells which are em-
bedded in an acellular fibrous stroma [38].
To the best of our knowledge, this is the first case of
GCT with heterologous sarcomatous changes observed
in the testis. The sarcomatous cells did not show any dif-
ferentiation, they were negative for desmin and SMA. As
in many soft tissue sarcomas, the cells were also positive
for pancytokeratin antibodies (AE1:AE3) in our case.
With the exception of one case which showed “some
evidence of rhabdomyosarcomatous differentiation [32]”,
the sarcoma cells in all other cases described in the ovar-
ies did not show any special differentiation [33-35].
One could argue that the observed sarcomatous compo-
nent originates from a concomitant germ cell tumor grow-
ing simultaneously with the granulosa tumor. Quite apart
from the fact that the tumor has been entirely processed
and no germ cell tumor remnant could be found, a
smooth transition from the differentiated to the sarcoma-
tous component could be observed. Moreover, the simul-
taneous occurrence of germ cell and stromal tumors in
the unilateral testis is extremely rare without any common
genetic or oncogenetic background [1]. In contrast to the
germ cells, the cells of the gonadal stroma tumors are dif-
ferentiated and not pluripotent; can therefore not give rise
to somatic type malignancies (carcinomas, differentiated
sarcomas) as the cells of teratomas do. The somatic type
malignancies arising in teratomas are well differentiated,
completely identical to the tumors originally developing in
other organs e.g. soft and nervous tissue, intestine etc.
[39], whereas the sarcomas described to date in stromal
tumors [32-35] were all composed of undifferentiatedspindle cells. It can be assumed that these tumors develop
from undifferentiated gonadal stroma.
A molecular characterization of sarcomatous changes
in ovarian GCT showed a down-regulation of the GCT-
specific genes such as inhibin, estrogen receptor and
FSH receptor [35]. A significant up-regulation of genes
with an inflammatory response was consistent with the
presence “of a marked inflammatory infiltrate”, which
was a striking morphological feature in our case as well.
However, contrary to these findings of McNeilage et al.
[34], the PR receptor was not down-regulated in our
case, but immunohistochemically strongly expressed.
Some authors claim that testicular GCT can be mis-
taken for lymphoma, metastatic carcinoma or even for
melanoma [12,35,36], but lymphoma and metastatic
carcinoma cells tend to spread in the interstitium be-
tween testicular tubules and usually do not form solid
tumor masses [1].
Immunohistochemistry is obviously helpful for achieving
a correct diagnosis. One must keep in mind, however, that
with few exceptions all types of sex cord/gonadal stroma
tumor cells show reactivity for the same antibodies. By and
large, but not in all cases, the tumor cells of GCT are posi-
tive for inhibin, calretinin, vimentin and CD 99 [20,31].
According to Renshaw et al. [18] SMA and S-100 are con-
stantly expressed in all testicular sex cord/gonadal stroma
tumors, but other authors cannot confirm these findings
[20,30]. CD 99 is consistently expressed, whereas EMA has
never been detected in the different types of sex cord/go-
nadal stroma tumors of the testis; these antibodies are thus
useful for the differential diagnosis stromal tumor vs. car-
cinoma metastasis [20,31,40]. Pancytokeratin and desmin
are often but not constantly detected [12,20,31]. Also very
useful to the diagnosis of these tumors is the detection of
estrogen (ER) and progesterone receptors (PR), and in this
connection PR are detected more often than ER (75% vs.
50%) [12]. PlAP immunohistochemistry is obviously the
best method to distinguish the stromal from the germ cell
tumors of the testes. The PR positivity in the sarcomatous
part of the tumor presented here is the only evidence that
these cells derive from the granulosa cells and not from the
supporting stroma.
A more difficult task is the correct classification of
poorly differentiated sex cord/stroma tumors, since the
granulosa and Sertoli cells can have a similar appear-
ance and can also express all of the immunohistochem-
ical markers discussed above. Almost all Leydig and
granulosa-cell tumors, but only about half of Sertoli-
cell tumors, react with inhibin and calretinin anti-
bodies [1]. A valuable marker could be the melan-A/
MART-1 (A 103) melanoma antibody, which is positive
in all Leydig and in many Seroli-cell tumors, but nega-
tive in GCTs [41]. CD 56 is constantly expressed in
GCT, but has never been tested in the diagnostics of
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differentiation in ovarian folliculogenesis [42].
One of the major problems of histological diagnosis of
testicular sex cord/stroma tumors is the prediction of ma-
lignancy. Atypical mitotic figures occur more frequently
and the mitotic index is significantly higher in malignant
tumors; vascular invasion, infiltrative margins, and necro-
sis are also associated with malignancy, but are not very
reliable [1] when used as a single criterion. The only reli-
able predictor of malignancy in GCT as in all other stro-
mal tumors is a tumor diameter > 5 cm [1,17,31].
Due to the few cases reported, our knowledge of the bio-
logical behavior and the clinical features of this tumor is still
fragmentary. The average age of the diseased men is 45 years
(Range 12 – 83 years) with an accumulation (45%) of cases
in the 5th and 6th decade (Table 1). In 65.5% of cases (21/32)
the tumors were smaller than 2 cm (1.7 cm in median,
range: 0.7 – 15 cm). Endocrine symptoms (gynecomastia,
loss of libido and potency) were observed only in six cases,
26 cases did not have such symptoms and in the other cases
this clinical information is missing (for references, see
Table 1). In the known cases the duration of clinical signs
ranged from a few months to 10 years! Nineteen case re-
ports included a follow up: 2 patients died of disease, one of
them 11 years after diagnosis [7,17], 3 patients died of unre-
lated diseases [12,20], 3 patients were alive with disease, one
of them 6 years after surgery [16,17,23]. The longest follow-
up of one of the 13 patients who were alive without evi-
dence of disease was 14 years [14].
Even this small series of cases shows that testicular
adult type GCTs behave in an aggressive manner in one
quarter of cases. The clinical problem is that there is no
specific therapy for these tumors. Various chemothera-
peutic agents and regimens have been used for patients
with metastatic disease with limited or no success. The
“prophylactic” retroperitoneal lymphadenectomy is an
option which is very successful in stage I diseases, but
not in the higher stages when the lymph nodes are
already affected [43].
In summary, we present a unique case of a testicular
granulosa cell tumor of adult type with a sarcomatous com-
ponent whose impact on the clinical course is unknown.
Conclusion
The correct classification of poorly differentiated sex
cord/stroma tumors can be difficult. Adult type testicu-
lar granulosa cell tumors (GCT) are rare sex cord–stro-
mal tumors challenging the diagnostic skills of surgical
pathologists. Rarely, these tumors can display a sarcoma-
tous component as described in the reported case.
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